• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research of molecular-targeting prevention against inflammatory diseases using chemical biology.

Planned Research

Project AreaPreventive medicine through inflammation cellular sociology
Project/Area Number 17H06398
Research Category

Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)

Allocation TypeSingle-year Grants
Review Section Complex systems
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

Sakai Toshiyuki  京都府立医科大学, 医学(系)研究科(研究院), 特任教授 (20186993)

Co-Investigator(Kenkyū-buntansha) 早川 芳弘  富山大学, 学術研究部薬学・和漢系, 教授 (10541956)
安田 周祐  京都府立医科大学, 医学(系)研究科(研究院), 助教 (10643398)
堀中 真野 (友杉 真野 / 堀中真野)  京都府立医科大学, 医学(系)研究科(研究院), 准教授 (80512037)
飯泉 陽介  京都府立医科大学, 医学(系)研究科(研究院), 助教 (20533178)
Project Period (FY) 2017-06-30 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥137,020,000 (Direct Cost: ¥105,400,000、Indirect Cost: ¥31,620,000)
Fiscal Year 2021: ¥26,260,000 (Direct Cost: ¥20,200,000、Indirect Cost: ¥6,060,000)
Fiscal Year 2020: ¥26,260,000 (Direct Cost: ¥20,200,000、Indirect Cost: ¥6,060,000)
Fiscal Year 2019: ¥26,260,000 (Direct Cost: ¥20,200,000、Indirect Cost: ¥6,060,000)
Fiscal Year 2018: ¥26,260,000 (Direct Cost: ¥20,200,000、Indirect Cost: ¥6,060,000)
Fiscal Year 2017: ¥31,980,000 (Direct Cost: ¥24,600,000、Indirect Cost: ¥7,380,000)
KeywordsSASP / スクリーニング / ケミカルバイオロジー / NK細胞 / がん予防 / 細胞老化 / 天然物 / IL-6 / T-bet / Eomes
Outline of Final Research Achievements

As a result of SASP inhibitor screening, we have newly found several natural compounds with SASP inhibitory activity. We found that oridonin, a terpenoid that is isolated from various Isodon plants, inhibited the activity of NF-κB and p38 in senescent cells induced by DNA damage. Furthermore, we have newly identified a binding protein of a known SASP inhibitor and found their involvement in SASP inhibitory activity.
We also identified compounds that activate NK cells, which attack cells that caused SASP, by screening, and clarified the mechanism of NK cell activation. We identified a number of natural compounds with NF-κB inhibitory activity against SASP and clarified their metastasis inhibitory effects in vivo.

Academic Significance and Societal Importance of the Research Achievements

SASPは炎症や発がんと関与しており、SASP制御機構の解明は重要な課題である。スクリーニングの結果、複数の天然化合物に新たにSASP阻害活性を見出した。さらに、既知のSASP阻害物質の結合タンパク質を同定し、SASP阻害活性との関与を見出している。また、活性化したNK細胞はSASPを起こした細胞を積極的に攻撃するため、NK細胞活性化物質のスクリーニングを行い、NK細胞活性化の作用機序を解明した。さらに、多くのNF-κB阻害活性を持つ天然物由来化合物を同定し、転移抑制作用についても明らかにした。これらのことはSASP制御の新しい機構を解明するための一助になる可能性が考えられる。

Report

(6 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Annual Research Report
  • 2019 Annual Research Report
  • 2018 Annual Research Report
  • 2017 Annual Research Report
  • Research Products

    (108 results)

All 2022 2021 2020 2019 2018 2017 Other

All Journal Article (56 results) (of which Int'l Joint Research: 16 results,  Peer Reviewed: 56 results,  Open Access: 38 results) Presentation (48 results) (of which Int'l Joint Research: 7 results,  Invited: 9 results) Book (2 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells2022

    • Author(s)
      Katayama Y, Yamada T, Tokuda S, Okura N, Nishioka N, Morimoto K, Tanimura K, Morimoto Y, Iwasaku M, Horinaka M, Sakai T, Kita K, Yano S, Takayama K
    • Journal Title

      Cancer Medicine

      Volume: 11 Issue: 4 Pages: 944-955

    • DOI

      10.1002/cam4.4504

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Tumor necrosis factor-related apoptosis-inducing ligand is a novel transcriptional target of runt-related transcription factor 12022

    • Author(s)
      Yoshida Tatsushi、Yamasaki Kenta、Tadagaki Kenjiro、Kuwahara Yasumichi、Matsumoto Akifumi、Sofovic Adem、Kondo Noriko、Sakai Toshiyuki、Okuda Tsukasa
    • Journal Title

      International Journal of Oncology

      Volume: 60 Issue: 1 Pages: 1-1

    • DOI

      10.3892/ijo.2021.5296

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.2022

    • Author(s)
      Tanimura K, Yamada T, Okada K, Nakai K, Horinaka M, Katayama Y, Morimoto K, Ogura Y, Takeda T, Shiotsu S, Ichikawa K, Watanabe S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Taniguchi H, Yoneda K, Matoba S, Sakai T, Uehara H, Yano S, Kusaba T, Katayama R, Takayama K.
    • Journal Title

      NPJ Precis Oncol.

      Volume: 6 Issue: 1 Pages: 5-5

    • DOI

      10.1038/s41698-021-00250-8

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells2022

    • Author(s)
      Yasuda Shusuke、Horinaka Mano、Iizumi Yosuke、Goi Wakana、Sukeno Mamiko、Sakai Toshiyuki
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 590 Pages: 55-62

    • DOI

      10.1016/j.bbrc.2021.12.098

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS52022

    • Author(s)
      Watanabe M, Boku S, Kobayashi K, Kurumida Y, Sukeno M, Masuda M, Mizushima K, Kato C, Iizumi Y, Hirota K, Naito Y, Mutoh M, Kameda T, Sakai T
    • Journal Title

      PNAS Nexus

      Volume: -

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells2022

    • Author(s)
      Takakura H, Horinaka M, Imai A, Aono Y, Nakao T, Miyamoto S, Iizumi Y, Watanabe M, Narita T, Ishikawa H, Mutoh M, Sakai T
    • Journal Title

      Journal of Clinical Biochemistry and Nutrition

      Volume: 70 Issue: 2 Pages: 93-102

    • DOI

      10.3164/jcbn.21-74

    • NAID

      130008165971

    • ISSN
      0912-0009, 1880-5086
    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.2022

    • Author(s)
      Isa R, Horinaka M, Tsukamoto T, Mizuhara K, Fujibayashi Y, Taminishi-Katsuragawa Y, Okamoto H, Yasuda S, Kawaji-Kanayama Y, Matsumura-Kimoto Y, Mizutani S, Shimura Y, Taniwaki M, Sakai T, Kuroda J.
    • Journal Title

      Int J Mol Sci.

      Volume: 23 Issue: 6 Pages: 2919-2936

    • DOI

      10.3390/ijms23062919

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Stabilization of CDK6 by ribosomal protein uS7, a target protein of the natural product fucoxanthinol2022

    • Author(s)
      Iizumi Y, Sowa Y, Goi W, Aono Y, Watanabe M, Kurumida Y, Kameda T, Akaji K, Kitagawa M, Sakai T.
    • Journal Title

      Communications Biology

      Volume: in press

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Identification of <i>Ophiocordyceps gracilioides</i> by Its Anti-tumor Effects through Targeting the NFκB-STAT3-IL-6 Inflammatory Pathway2021

    • Author(s)
      Shin MK, Sasaki F, Ki DW, Win NN, Morita H, Hayakawa Y
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 44 Issue: 5 Pages: 686-690

    • DOI

      10.1248/bpb.b20-01032

    • NAID

      130008033230

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2021-05-01
    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer2021

    • Author(s)
      Ono H, Horinaka M, Sukeno M, Morita M, Yasuda S, Nishimoto E, Konishi E, Sakai T
    • Journal Title

      Cancer Science

      Volume: 112 Issue: 10 Pages: 4166-4175

    • DOI

      10.1111/cas.15071

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer.2021

    • Author(s)
      Tanimura K, Yamada T, Horinaka M, Katayama Y, Fukui S, Morimoto K, Nakano T, Tokuda S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Yoneda K, Yano S, Sakai T, Takayama K.
    • Journal Title

      Cancer Lett.

      Volume: 522 Pages: 119-128

    • DOI

      10.1016/j.canlet.2021.09.018

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The combination of cigarette smoking and alcohol consumption synergistically increases reactive carbonyl species in human male plasma2021

    • Author(s)
      Mure K, Tomono S, Mure M, Horinaka M, Mutoh M, Sakai T, Ishikawa H, Wakabayashi K
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 22 Issue: 16 Pages: 9043-9043

    • DOI

      10.3390/ijms22169043

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial2021

    • Author(s)
      Ishikawa H、Mutoh M、Sato Y、Doyama H、Tajika M、Tanaka S、Horimatsu T、Takeuchi Y、Kashida H、Tashiro J、Ezoe Y、Nakajima T、Ikematsu H、Hori S、Suzuki S、Otani T、Takayama T、Ohda Y、Mure K、Wakabayashi K、Sakai T
    • Journal Title

      The Lancet Gastroenterology & Hepatology

      Volume: - Issue: 6 Pages: 474-481

    • DOI

      10.1016/s2468-1253(21)00018-2

    • Related Report
      2021 Annual Research Report 2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anti-inflammatory effects of Morus alba Linne bark on the activation of toll-like receptors and imiquimod-induced ear edema in mice2021

    • Author(s)
      Umeyama L, Hardianti B, Kasahara S, Dibwe DF, Awale S, Yokoyama S, Hayakawa Y
    • Journal Title

      BMC Complementary Medicine and Therapies

      Volume: 21 Issue: 1

    • DOI

      10.1186/s12906-021-03291-5

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Anti-metastatic effects of ergosterol peroxide from the entomopathogenic fungus Ophiocordyceps gracilioides on 4T1 breast cancer cells2021

    • Author(s)
      Shin MK, Sasaki F, Ki DW, Win NN, Morita H, Hayakawa Y
    • Journal Title

      Journal of Natural Medicines

      Volume: 75 Issue: 4 Pages: 824-832

    • DOI

      10.1007/s11418-021-01520-2

    • NAID

      40022680493

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of cell-intrinsic NF-κB activity and metastatic abilities of breast cancer by aloe-emodin and emodic-acid isolated from Asphodelus microcarpus2021

    • Author(s)
      Abdellatef AA, Fathy M, Mohammed AEI, Bakr MSA, Ahmed AH, Abbass HS, El-Desoky AH, Morita H, Nikaido T, Hayakawa Y
    • Journal Title

      Journal of Natural Medicines

      Volume: 75 Issue: 4 Pages: 840-853

    • DOI

      10.1007/s11418-021-01526-w

    • NAID

      40022680983

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Synthetic E-guggulsterone derivative GSD-1 inhibits NF-κB signaling and suppresses the metastatic potential of breast cancer cells2021

    • Author(s)
      Abdellatef AA, Zhou Y, Yamada A, Elmekkawy SA, Kohyama A, Yokoyama S, Meselhy MR, Matsuya Y, Sakurai H, Hayakawa Y
    • Journal Title

      Biomedicine & Pharmacotherapy

      Volume: 140 Pages: 111737-111737

    • DOI

      10.1016/j.biopha.2021.111737

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Design and synthesis of 2-substituted-4-benzyl-5-methylimidazoles as new potential anti-breast cancer agents to inhibit oncogenic STAT3 functions2021

    • Author(s)
      Beshay BY, Abdellatef AA, Loksha YM, Fahmy SM, Habib NS, Bekhit AEA, Georghiou PE, Hayakawa Y, Bekhit AA
    • Journal Title

      Bioorganic Chemistry

      Volume: 113 Pages: 105033-105033

    • DOI

      10.1016/j.bioorg.2021.105033

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] NKG2D defines tumor‐reacting effector CD8+ T cells within tumor microenvironment2021

    • Author(s)
      Mojic M, Shitaoka K, Ohshima C, Ucche S, Lyu F, Hamana H, Tahara H, Kishi H, Hayakawa Y
    • Journal Title

      Cancer Science

      Volume: 112 Issue: 9 Pages: 3484-3490

    • DOI

      10.1111/cas.15050

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Flavanols and flavanes from Crinum asiaticum and their effects on LPS signaling pathway through the inhibition of NF-κB activation2021

    • Author(s)
      Do KM, Shin MK, Kodama T, Win NN, Prema P, Nguyen HM, Hayakawa Y, Morita H
    • Journal Title

      Planta Medica

      Volume: - Issue: 11 Pages: 913-920

    • DOI

      10.1055/a-1585-5877

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation2021

    • Author(s)
      Sasaki S, Zhang D, Iwabuchi S, Tanabe Y, Hashimoto S, Yamauchi A, Hayashi K, Tsuchiya H, Hayakawa Y, Baba T, Mukaida N
    • Journal Title

      Cancer Science

      Volume: 112 Issue: 12 Pages: 4883-4893

    • DOI

      10.1111/cas.15150

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] SOX10 regulates melanoma immunogenicity through an IRF4-IRF1 axis2021

    • Author(s)
      Yokoyama S, Takahashi A, Kikuchi R, Nishibu S, Lo JA, Hejna M, Moon WM, Kato S, Zhou Y, Hodi FS, Song JS, Sakurai H, Fisher DE, Hayakawa Y
    • Journal Title

      Cancer Research

      Volume: 81 Issue: 24 Pages: 6131-6141

    • DOI

      10.1158/0008-5472.can-21-2078

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis2021

    • Author(s)
      Taniguchi Keiko、Kageyama Susumu、Moyama Chiami、Ando Shota、Ii Hiromi、Ashihara Eishi、Horinaka Mano、Sakai Toshiyuki、Kubota Shigehisa、Kawauchi Akihiro、Nakata Susumu
    • Journal Title

      Cancer Gene Therapy

      Volume: - Issue: 1 Pages: 37-48

    • DOI

      10.1038/s41417-020-00287-0

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Rabdosianone I, a Bitter Diterpene from an Oriental Herb, Suppresses Thymidylate Synthase Expression by Directly Binding to ANT2 and PHB22021

    • Author(s)
      Watanabe M, Yamada Y, Kurumida Y, Kameda T, Sukeno M, Iizuka-Ohashi M, Sowa Y, Iizumi Y, Takakura H, Miyamoto S, Sakai T, Mutoh M.
    • Journal Title

      Cancers.

      Volume: 13 Issue: 5 Pages: 982-982

    • DOI

      10.3390/cancers13050982

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Establishment of bioluminescent imaging model using murine T cell lymphoma susceptive to NK cell-dependent immune-surveillance.2021

    • Author(s)
      Fujiwara T, Miyazato K, Takahashi K, Hayakawa Y.
    • Journal Title

      J Immunol Methods.

      Volume: 491 Pages: 112993-112993

    • DOI

      10.1016/j.jim.2021.112993

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anti-metastatic Effects of Baicalein by Targeting STAT3 Activity in Breast Cancer Cells2020

    • Author(s)
      Susmitha Gorrepotu D, Miyazato K, Ogura K, Yokoyama S, Hayakawa Y.
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 43 Issue: 12 Pages: 1899-1905

    • DOI

      10.1248/bpb.b20-00571

    • NAID

      130007948716

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2020-12-01
    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition.2020

    • Author(s)
      Boku S, Watanabe M, Sukeno M, Yaoi T, Hirota K, Iizuka-Ohashi M, Itoh K, Sakai T.
    • Journal Title

      Cancers (Basel).

      Volume: 12 Issue: 5 Pages: 1097-1097

    • DOI

      10.3390/cancers12051097

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA.2020

    • Author(s)
      Sugimoto Y, Katsumi Y, Iehara T, Kaneda D, Tomoyasu C, Ouchi K, Yoshida H, Miyachi M, Yagyu S, Kikuchi K, Tsuchiya K, Kuwahara Y, Sakai T, Hosoi H.
    • Journal Title

      Mol Cancer Ther.

      Volume: 19 Issue: 10 Pages: 1992-2000

    • DOI

      10.1158/1535-7163.mct-20-0243

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression.2020

    • Author(s)
      Umemura S, Sowa Y, Iizumi Y, Kitawaki J, Sakai T.
    • Journal Title

      Cancer Sci.

      Volume: 111 Issue: 6 Pages: 2052-2061

    • DOI

      10.1111/cas.14414

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Very long-term treatment with a Lactobacillus probiotic preparation, Lactobacillus Casei strain Shirota, suppresses weight loss in the elderly.2020

    • Author(s)
      Ishikawa H, Mutoh M, Yoshimura K, Fujii G, Nakamura T, Takeshita T, Wakabayashi K, Sakai T.
    • Journal Title

      Nutrients

      Volume: 12 Issue: 6 Pages: 1599-1599

    • DOI

      10.3390/nu12061599

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Artesunate Inhibits Intestinal Tumorigenesis through Inhibiting Wnt Signaling.2020

    • Author(s)
      Hamoya T, Fujii G, Iizumi Y, Narita T, Komiya M, Matsuzawa Y, Miki K, Kondo T, Kishimoto S, Watanabe K, Wakabayashi K, Sakai T, Toshima J, Mutoh M
    • Journal Title

      Carcinogenesis

      Volume: 42 Issue: 1 Pages: 148-58

    • DOI

      10.1093/carcin/bgaa084

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Anti-Metastatic Effects of Curcumin Analogues in a Mouse Breast Cancer Model2020

    • Author(s)
      Ucche S, Murwanti R, Ritmaleni, Hayakawa Y.
    • Journal Title

      BPB Reports

      Volume: 3 Issue: 2 Pages: 76-79

    • DOI

      10.1248/bpbreports.3.2_76

    • NAID

      130007944871

    • ISSN
      2434-432X
    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Pharmacological targeting of natural killer cells for cancer immunotherapy.2020

    • Author(s)
      Miyazato K, Hayakawa Y.
    • Journal Title

      Cancer Sci.

      Volume: 111 Issue: 6 Pages: 1869-1875

    • DOI

      10.1111/cas.14418

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells2020

    • Author(s)
      Miyazato K, Tahara H, Hayakawa Y.
    • Journal Title

      Cancer Sci.

      Volume: 111 Issue: 8 Pages: 2770-2778

    • DOI

      10.1111/cas.14538

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Anti&#8209;inflammatory compounds moracin O and P from Morus alba Linn. (Sohakuhi) target the NF&#8209;κB pathway.2020

    • Author(s)
      Hardianti B, Umeyama L, Li F, Yokoyama S, Hayakawa Y.
    • Journal Title

      Mol Med Rep.

      Volume: 22 Issue: 6 Pages: 5385-5391

    • DOI

      10.3892/mmr.2020.11615

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Anti-inflammatory effect of fermented brown rice and rice bran with Aspergillus oryzae on mice.2020

    • Author(s)
      Umeyama L, Kasahara S, Sugawara M, Yokoyama S, Saiki I, Hayakawa Y.
    • Journal Title

      Traditional & Kampo Medicine.

      Volume: 8 Issue: 1 Pages: 60-65

    • DOI

      10.1002/tkm2.1270

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.2020

    • Author(s)
      Kawarazaki A, Horinaka M, Yasuda S, Kawashima H, Numajiri T, Sakai T.
    • Journal Title

      J BUON.

      Volume: 25 Pages: 464-471

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Histone deacetylase inhibitor OBP-801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1-dependent apoptosis.2020

    • Author(s)
      Chihara Y, Iizumi Y, Horinaka M, Watanabe M, Goi W, Morita M, Nishimoto E, Sowa Y, Yamada T, Takayama K, Sakai T.
    • Journal Title

      Int J Oncol.

      Volume: 56 Pages: 848-856

    • DOI

      10.3892/ijo.2020.4969

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non?Small Cell Lung Cancer2020

    • Author(s)
      Okura N, Nishioka N, Yamada T, Taniguchi H, Tanimura K, Katayama Y, Yoshimura A, Watanabe S, Kikuchi T, Shiotsu S, Kitazaki T, Nishiyama A, Iwasaku M, Kaneko Y, Uchino J, Uehara H, Horinaka M, Sakai T, Tanaka K, Kozaki R, Yano S, Takayama K.
    • Journal Title

      Clinical Cancer Research

      Volume: 26 Issue: 9 Pages: 2244-2256

    • DOI

      10.1158/1078-0432.ccr-19-2321

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Anti-inflammatory activities of isopimara-8(14),-15-diene diterpenoids and mode of action of kaempulchraols P and Q from Kaempferia pulchra rhizomes2020

    • Author(s)
      Nwet WN, Hardianti B, Kasahara S, Ngwe H, Hayakawa Y, Morita H.
    • Journal Title

      Bioorg Med Chem.

      Volume: 30 Issue: 2 Pages: 126841-126841

    • DOI

      10.1016/j.bmcl.2019.126841

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Anti-inflammatory activities of isopimara-8(9),15-diene diterpenoids and mode of action of kaempulchraols B-D from Kaempferia pulchra rhizomes2020

    • Author(s)
      N.N. Win, B. Hardianti, H. Ngwe, Y. Hayakawa, H. Morita
    • Journal Title

      J Nat Med

      Volume: 74 Issue: 2 Pages: 487-494

    • DOI

      10.1007/s11418-020-01389-7

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain S-PT84 via the TNFα pathway in human colon cancer cells.2019

    • Author(s)
      Yasuda S, Horinaka M, Sakai T.
    • Journal Title

      Oncol Lett.

      Volume: 18 Pages: 4253-4261

    • DOI

      10.3892/ol.2019.10739

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Effect of physical fitness on colorectal tumor development in patients with familial adenomatous polyposis2019

    • Author(s)
      Nakamura T, Ishikawa H, Sakai T, Ayabe M, Wakabayashi K, Mutoh M, Matsuura N.
    • Journal Title

      Medicine

      Volume: 98 Issue: 38 Pages: e17076-e17076

    • DOI

      10.1097/md.0000000000017076

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Cycloartenyl Ferulate and β-Sitosteryl Ferulate - Steryl Ferulates of γ-Oryzanol - Suppress Intracellular Reactive Oxygen Species in Cell-based System2019

    • Author(s)
      Yasuda S, Sowa Y, Hashimoto H, Nakagami T, Tsuno T, Sakai T.
    • Journal Title

      Journal of Oleo Science

      Volume: 68 Issue: 8 Pages: 765-768

    • DOI

      10.5650/jos.ess19054

    • NAID

      130007686318

    • ISSN
      1345-8957, 1347-3352
    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Utility of mesalazine in familial adenomatous polyposis: clinical report of reduction of polyp size in patients with ulcerative colitis, and safety examination in familial adenomatous polyposis patients.2019

    • Author(s)
      Ishikawa H, Mutoh M, Abe T, Nakajima T, Takeuchi Y, Ezoe Y, Wakabayashi K, Doyama H, Sakai T.
    • Journal Title

      Pharmacology

      Volume: 104 Issue: 1-2 Pages: 51-56

    • DOI

      10.1159/000500226

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma.2019

    • Author(s)
      Nakagawa N, Kikuchi K, Yagyu S, Miyachi M, Iehara T, Tajiri T, Sakai T, Hosoi H.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 512 Issue: 3 Pages: 524-530

    • DOI

      10.1016/j.bbrc.2019.03.038

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Macrophage‐specific hypoxia‐inducible factor‐1α deletion suppresses the development of liver tumors in high‐fat diet‐fed obese and diabetic mice2019

    • Author(s)
      Takikawa Akiko、Usui Isao、Fujisaka Shiho、Tsuneyama Koichi、Okabe Keisuke、Nakagawa Takashi、Nawaz Allah、Kado Tomonobu、Jojima Teruo、Aso Yoshimasa、Hayakawa Yoshihiro、Yagi Kunikimi、Tobe Kazuyuki
    • Journal Title

      Journal of Diabetes Investigation

      Volume: in press Issue: 6 Pages: 1-8

    • DOI

      10.1111/jdi.13047

    • NAID

      120006980551

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Molecular mechanisms of natural compounds in cell death induction and sensitization to chemotherapeutic drugs in lung cancer.2019

    • Author(s)
      Wattanathamsan O, Hayakawa Y, Pongrakhananon V.
    • Journal Title

      Phytother Res.

      Volume: 33 Issue: 10 Pages: 2531-2547

    • DOI

      10.1002/ptr.6422

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death2019

    • Author(s)
      Xu Xiaoou、Eshima Shizuka、Kato Shinichiro、Fisher David E.、Sakurai Hiroaki、Hayakawa Yoshihiro、Yokoyama Satoru
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 19 Issue: 2 Pages: 627-636

    • DOI

      10.1158/1535-7163.mct-19-0451

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting voltage-dependent anion channel 1 and 22018

    • Author(s)
      Aono Yuichi、Horinaka Mano、Iizumi Yosuke、Watanabe Motoki、Taniguchi Tomoyuki、Yasuda Shusuke、Sakai Toshiyuki
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 505 Issue: 4 Pages: 1203-1210

    • DOI

      10.1016/j.bbrc.2018.10.050

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma2018

    • Author(s)
      Hagiwara Nobuhisa、Watanabe Motoki、Iizuka-Ohashi Mahiro、Yokota Isao、Toriyama Seijiro、Sukeno Mamiko、Tomosugi Mitsuhiro、Sowa Yoshihiro、Hongo Fumiya、Mikami Kazuya、Soh Jintetsu、Fujito Akira、Miyashita Hiroaki、Morioka Yukako、Miki Tsuneharu、Ukimura Osamu、Sakai Toshiyuki
    • Journal Title

      Cancer Letters

      Volume: 431 Pages: 182-189

    • DOI

      10.1016/j.canlet.2018.05.025

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells.2018

    • Author(s)
      Iizuka-Ohashi M1,2, Watanabe M1, Sukeno M1, Morita M1, Hoang NTH3, Kuchimaru T, Kizaka-Kondoh S, Sowa Y1 Sakaguchi K, Taguchi T, Sakai T.
    • Journal Title

      Oncotarget.

      Volume: 9 Issue: 28 Pages: 19597-19612

    • DOI

      10.18632/oncotarget.24696

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Lung-resident natural killer cells control pulmonary tumor growth in mice2018

    • Author(s)
      Yamamoto Yutaka、Miyazato Kiho、Takahashi Kei、Yoshimura Naoki、Tahara Hideaki、Hayakawa Yoshihiro
    • Journal Title

      Cancer Science

      Volume: 109 Issue: 9 Pages: 2670-2676

    • DOI

      10.1111/cas.13703

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] NK Cells Control Tumor-Promoting Function of Neutrophils in Mice2018

    • Author(s)
      Ogura K, Sato-Matsushita M, Yamamoto S, Hori T, Sasahara M, Iwakura Y, Saiki I, Tahara H, Hayakawa Y
    • Journal Title

      Cancer Immunol Res

      Volume: 印刷中 Issue: 3 Pages: 348-357

    • DOI

      10.1158/2326-6066.cir-17-0204

    • NAID

      120006402039

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Ribosomal protein S3 regulates XIAP expression independently of the NF-κB pathway in breast cancer cells2017

    • Author(s)
      Ono H, Iizumi Y, Goi W, Sowa Y, Taguchi T, Sakai T
    • Journal Title

      Oncol Rep

      Volume: 38 Issue: 5 Pages: 3205-3210

    • DOI

      10.3892/or.2017.6008

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The Dark Side of IFN-g: Its Role in Promoting Cancer Immunoevasion.2017

    • Author(s)
      Mojic M, Takeda K, Hayakawa Y.
    • Journal Title

      Int J Mol Sci

      Volume: 28 Issue: 1 Pages: 1-13

    • DOI

      10.3390/ijms19010089

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] 延命草成分オリドニンはp38とNF-κBを介して老化関連分泌現象を阻害する2022

    • Author(s)
      安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
    • Organizer
      第21回分子予防環境医学研究会大会
    • Related Report
      2021 Annual Research Report
  • [Presentation] EGFR-T790M変異陽性肺がんの生物学的特徴に関する基礎的検討2021

    • Author(s)
      片山勇輝, 西岡直哉, 大倉直子, 森本健司, 谷村恵子, 堀中真野, 酒井敏行, 矢野聖二, 山田忠明
    • Organizer
      第25回日本がん分子標的治療学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] シスチン・グルタミン酸トランスポーターxCTの阻害はROS依存的にvorinostatの感受性を増強する2021

    • Author(s)
      渡邉元樹, 朴将源, 酒井敏行
    • Organizer
      第25回日本がん分子標的治療学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] アカデミア発新薬の上市を目指した企業への導出の実際2021

    • Author(s)
      酒井敏行
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ALK肺癌におけるALKとHER3の共阻害による新たな治療戦略2021

    • Author(s)
      谷村恵子, 山田忠明, 米田和恵, 堀中真野, 酒井敏行, 上原久典, 矢野聖二, 片山量平
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] PIK3CA変異大腸癌細胞においてグルタミン代謝阻害がアスピリンに対する感受性を促進する2021

    • Author(s)
      朴将源, 渡邉元樹, 飯塚まひろ, 曽和義広, 増田光治, 飯泉陽介, 成田匠, 佐竹悠良, 酒井敏行, 武藤倫弘
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Acquired resistance mechanism of cancer cells to anti-tumor immunity2021

    • Author(s)
      Yoshihiro Hayakawa
    • Organizer
      The 27th International Symposium on Molecular Cell Biology of Macrophages
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] がん細胞の免疫適応機構に関わる分子探索研究2021

    • Author(s)
      早川芳弘
    • Organizer
      第85回日本インターフェロン・サイトカイン学会学術集会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] Paradoxical roles of host immunity in controlling tumor progression and metastasis2021

    • Author(s)
      早川芳弘, 竹田和由
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] 健康長寿社会の実現に向けた生体防御システムの理解と和漢薬の可能性2021

    • Author(s)
      早川芳弘
    • Organizer
      第94回日本生化学会大会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] Immuno-regulatory role of PP2A on anti-tumor effector function of NK cells2021

    • Author(s)
      山前結,川田学,早川芳弘
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Role of MHC class I recognition in regulating anti-tumor effector function of lung-tissue resident mature NK cell2021

    • Author(s)
      Ka He, Yui Yamamae, Hideaki Tahara, Yoshihiro Hayakawa.
    • Organizer
      第50回日本免疫学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 新規がん予防標的GGCTは、がん細胞にHIF-1α発現を誘導しワールブルク効果を促進する2021

    • Author(s)
      谷口恵香, 影山進, 茂山千愛美, 安藤翔太, 飯居宏美, 芦原英司, 堀中真野, 酒井敏行, 窪田成寿, 河内明宏, 中田晋
    • Organizer
      第20回分子予防環境医学研究会大会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 「先制医療」の実現に向けた戦略的研究2021

    • Author(s)
      堀中真野, 酒井敏行
    • Organizer
      第91回日本衛生学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 新規がん予防標的GGCTは、がん細胞にHIF-1 alpha発現を誘導して好気性解糖を促進する2021

    • Author(s)
      谷口恵香, 影山進, 茂山千愛美, 安藤翔太, 飯居宏美, 芦原英司, 堀中真野, 酒井敏行, 河内明宏, 中田晋
    • Organizer
      第91回日本衛生学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 細胞外グルタミン濃度はがん予防薬の感受性に影響する2021

    • Author(s)
      渡邉元樹, 朴将源, 宮本景子, 曽和義広, 飯泉陽介, 増田光治, 成田匠, 中尾俊雅, 武藤倫弘, 酒井敏行
    • Organizer
      第91回日本衛生学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 延命草の苦味成分rabdosianone Ⅰはミトコンドリア内膜タンパク質ANT2とPHB2に直接結合し、thymidylate synthaseの発現を抑制する2020

    • Author(s)
      渡邉元樹, 酒井敏行
    • Organizer
      第24回日本がん分子標的治療学会学術集会
    • Related Report
      2020 Annual Research Report
  • [Presentation] ALK融合遺伝子陽性肺がんの初期治療抵抗性機構の解明とその克服法の開発2020

    • Author(s)
      谷村恵子, 山田忠明, 岡田康太郎, 米田和恵, 堀中真野, 酒井敏行, 矢野聖二, 片山量平
    • Organizer
      第24回日本がん分子標的治療学会学術集会
    • Related Report
      2020 Annual Research Report
  • [Presentation] EGFR遺伝子変異陽性肺がんの初期治療抵抗性に対する新規AXL阻害薬ONO-7475の効果2020

    • Author(s)
      大倉直子, 西岡直哉, 谷村恵子, 矢野聖二, 小崎龍平, 堀中真野, 酒井敏行, 山田忠明
    • Organizer
      第24回日本がん分子標的治療学会学術集会
    • Related Report
      2020 Annual Research Report
  • [Presentation] HER3 is a potent therapeutic target for prevention of tolerant cells to ALK inhibitors in ALK-rearranged cancer.2020

    • Author(s)
      谷村恵子, 米田和恵, 矢野聖二, 堀中真野, 酒井敏行, 片山量平, 山田忠明
    • Organizer
      第79回日本癌学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression.2020

    • Author(s)
      楳村史織, 曽和義広, 飯泉陽介, 酒井敏行
    • Organizer
      第79回日本癌学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] xCT inhibition increases sensitivity to vorinostat in a ROS-dependent manner.2020

    • Author(s)
      渡邉元樹, 宮本景子, 朴将源, 阪口晃一, 田口哲也, 曽和義広, 飯泉陽介, 増田光治, 成田匠, 鱧屋隆博, 酒井敏行, 武藤倫弘
    • Organizer
      第79回日本癌学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] ONO-7475, a novel AXL inhibitor, suppresses the adaptive resistance to initial EGFR-TKI treatment in EGFR-mutated NSCLC.2020

    • Author(s)
      大倉直子, 谷口寛和, 谷村恵子, 堀中真野, 酒井敏行, 田中昴平, 小崎龍平, 矢野聖二, 山田忠明
    • Organizer
      第79回日本癌学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] BRCAness誘導分子の探索2020

    • Author(s)
      小野寿子, 堀中真野, 酒井敏行
    • Organizer
      第65回日本人類遺伝学会大会
    • Related Report
      2020 Annual Research Report
  • [Presentation] ファースト/ベスト・イン・クラスのMEK阻害剤トラメチニブ(商品目メキニスト) -その発見に至った経緯-2020

    • Author(s)
      酒井 敏行
    • Organizer
      第5回橋渡し研究戦略的推進プログラム シンポジウム
    • Related Report
      2019 Annual Research Report
  • [Presentation] 「先制医療」の時代における日本衛生学会の役割2020

    • Author(s)
      酒井 敏行
    • Organizer
      第90回日本衛生学会学術総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ファースト・イン・クラスかつベスト・イン・クラスのMEK阻害剤トラメチニブ: 過去、現在、未来2019

    • Author(s)
      酒井 敏行
    • Organizer
      第23回日本がん分子標的治療学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ファースト・イン・クラスのMEK阻害剤トラメチニブなどの創薬から学んだこと-我が国の産学連携研究のあり方への提言2019

    • Author(s)
      酒井 敏行
    • Organizer
      medU-net年次総会・シンポジウム
    • Related Report
      2019 Annual Research Report
  • [Presentation] がん抑制遺伝子RBを萃点として捉えた、新しいがんの予防法、診断法、治療法の開発2019

    • Author(s)
      酒井 敏行
    • Organizer
      国立研究開発法人医薬基盤・健康・栄養研究所 国立健康・栄養研究所 健栄研セミナー
    • Related Report
      2019 Annual Research Report
  • [Presentation] RBを萃点として捉えた新規がん治療法・予防法の開発 -first/best-in-classのMEK阻害剤トラメチニブ及びがん予防ジュースの開発の現状-2019

    • Author(s)
      酒井 敏行
    • Organizer
      国立がん研究センター セミナー
    • Related Report
      2019 Annual Research Report
  • [Presentation] ファースト/ベスト・イン・クラスMEK阻害剤トラメチニブ(商品名メキニスト)等の創薬経験から2019

    • Author(s)
      酒井 敏行
    • Organizer
      第92回日本生化学会大会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 分子標的癌予防医学2019

    • Author(s)
      酒井 敏行
    • Organizer
      ルイ・パストゥール医学研究センター 2019年度バイオ・ソサエティ医学入門講座
    • Related Report
      2019 Annual Research Report
  • [Presentation] 京都府立医大発の画期的抗がん剤 -その歴史と現状-2019

    • Author(s)
      酒井 敏行
    • Organizer
      第13回府民公開講座
    • Related Report
      2019 Annual Research Report
  • [Presentation] 耐久高校での夢~画期的抗がん剤開発の実現2019

    • Author(s)
      酒井 敏行
    • Organizer
      令和元年度関西耐久会 特別講演
    • Related Report
      2019 Annual Research Report
  • [Presentation] アカデミアと企業の相互理解の難しさ2019

    • Author(s)
      酒井 敏行
    • Organizer
      第10回スクリーニング学研究会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ファースト・イン・クラスのMEK 阻害剤トラメチニブの発見2019

    • Author(s)
      酒井 敏行
    • Organizer
      第3回 薬学トップランナー研究講演会
    • Related Report
      2019 Annual Research Report
  • [Presentation] Role of NK cells in controlling cancer growth and metastasis2019

    • Author(s)
      早川 芳弘
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] NK細胞の多様性とがん免疫応答における役割2019

    • Author(s)
      早川 芳弘
    • Organizer
      第105回日本消化器病学会総会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] Role of NK cells in controlling cancer growth and metastasis2019

    • Author(s)
      早川 芳弘
    • Organizer
      The 6th ICPAPS and The 3rd&nbsp;ASEAN PharmNET 2019
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Pre-clinical&nbsp;animal models for studying cancer immunology2019

    • Author(s)
      早川 芳弘
    • Organizer
      1st Preclinical Toxicity and&nbsp;Efficacy Assessment of Medicines and Chemicals Symposium
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Targeting natural killer cells to regulate cancer-associated inflammation2018

    • Author(s)
      Hayakawa Y
    • Organizer
      1st International Seminar on Pharmaceutical 2018; Manado, Indonesia
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Targeting inflammatory tumor microenvironment for developing new cancer treatment2018

    • Author(s)
      Hayakawa Y
    • Organizer
      The Third International Symposium on Toyama-Asia-Africa Pharmaceutical Network; Toyama
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] クルクミンによるがん予防効果の分子機構の解析2018

    • Author(s)
      飯泉陽介、小野寿子、後居和佳奈、曽和義広、酒井敏行
    • Organizer
      第17回 分子予防環境医学研究会
    • Related Report
      2017 Annual Research Report
  • [Presentation] セサミノール結合タンパク質ANT2の発見がもたらすcyclin D1の多面的制御機構の解明2018

    • Author(s)
      渡邉元樹、飯泉陽介、助野真美子、曽和義広、酒井敏行
    • Organizer
      第17回 分子予防環境医学研究会
    • Related Report
      2017 Annual Research Report
  • [Presentation] クルクミンによるがん予防効果の分子機構解明の試み2018

    • Author(s)
      飯泉陽介、小野寿子、後居和佳奈、曽和義広、酒井敏行
    • Organizer
      第88回 日本衛生学会学術総会
    • Related Report
      2017 Annual Research Report
  • [Presentation] セサミノール結合タンパク質ANT2の発見がもたらす新たな細胞周期調節機構の解明2018

    • Author(s)
      渡邉元樹、飯泉陽介、助野真美子、曽和義広、酒井敏行
    • Organizer
      第88回 日本衛生学会学術総会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Anti-metastatic effect of immunomodulatory drugs (IMiDs) through the regulation of NK cell homeostasis2017

    • Author(s)
      Miyazato K, Tahara H, Hayakawa Y
    • Organizer
      The 5th Annual Meeting of the International Cytokine and Interferon Society (ICIS2017)
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] NK cells control tumor-promoting function of neutrophils2017

    • Author(s)
      Ogura K, Sato-Matsushita M, Hori T, Iwakura Y, Tahara H, Saiki I, Hayakawa Y
    • Organizer
      The 5th Annual Meeting of the International Cytokine and Interferon Society (ICIS2017)
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Book] THE創薬 -少資源国家にっぽんの生きる道-2021

    • Author(s)
      酒井敏行
    • Publisher
      薬事日報社
    • ISBN
      9784840815536
    • Related Report
      2020 Annual Research Report
  • [Book] Precision Medicine 2020年4月号2020

    • Author(s)
      小野寿子、酒井敏行
    • Total Pages
      4
    • Publisher
      北隆館
    • Related Report
      2019 Annual Research Report
  • [Remarks] がん免疫応答における自然リンパ球であるナチュラルキラー細胞の新たな機能を解明

    • URL

      https://www.u-toyama.ac.jp/education/news/2018/0131.html

    • Related Report
      2017 Annual Research Report
  • [Patent(Industrial Property Rights)] RB活性化食品組成物2022

    • Inventor(s)
      酒井 敏行、堀中 真野、増田 光治
    • Industrial Property Rights Holder
      京都府公立大学法人、築野食品工業株式会社
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2022-036535
    • Filing Date
      2022
    • Related Report
      2021 Annual Research Report

URL: 

Published: 2017-07-04   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi